We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation
AGTC

Delisted

AGTC was delisted on the 30th of November, 2022.

Back to rankings

47 hedge funds and large institutions have $8.49M invested in Applied Genetic Technologies Corporation in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,300% more call options, than puts

Call options by funds: $72K | Put options by funds: $3K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less funds holding

Funds holding: 53 → 47 (-6)

42% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 12

47% less capital invested

Capital invested by funds: $16.2M → $8.49M (-$7.69M)

74% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 19

Holders
47
Holders Change
-6
Holders Change %
-11.32%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
5
Reduced
19
Closed
12
Calls
$72K
Puts
$3K
Net Calls
+$69K
Net Calls Change
+$540K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$167K
2
CG
Colony Group
Massachusetts
+$83.8K
3
HF
HRT Financial
New York
+$62K
4
Stifel Financial
Stifel Financial
Missouri
+$57.2K
5
BRWA
B. Riley Wealth Advisors
Florida
+$17.8K

Top Sellers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
-$2.09M
2
IC
Ikarian Capital
Texas
-$440K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$217K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$216K
5
BlackRock
BlackRock
New York
-$173K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.53M – – –
PCM
2
Portolan Capital Management
Massachusetts
$1.24M – – –
Millennium Management
3
Millennium Management
New York
$1.15M -$133K -149,230 -9%
IVM
4
InterWest Venture Management
California
$1.08M – – –
BlackRock
5
BlackRock
New York
$711K -$173K -194,380 -17%
SM
6
Sabby Management
Florida
$625K -$141K -158,084 -16%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$523K -$902 -1,012 -0.1%
CG
8
Colony Group
Massachusetts
$254K +$83.8K +93,952 +40%
Renaissance Technologies
9
Renaissance Technologies
New York
$235K +$167K +186,900 +157%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$202K – – –
BCM
11
Bridgeway Capital Management
Texas
$120K -$12.9K -14,525 -9%
State Street
12
State Street
Massachusetts
$98K – – –
Ameriprise
13
Ameriprise
Minnesota
$96K -$2.85K -3,200 -3%
KCM
14
Knoll Capital Management
Florida
$77K – – –
Stifel Financial
15
Stifel Financial
Missouri
$62K +$57.2K +64,200 +387%
Wells Fargo
16
Wells Fargo
California
$59K -$7.11K -7,978 -9%
Northern Trust
17
Northern Trust
Illinois
$58K -$9 -10 -0%
HF
18
HRT Financial
New York
$53K +$62K +69,536 New
SC
19
Shay Capital
New York
$39K – – –
Two Sigma Advisers
20
Two Sigma Advisers
New York
$34K -$65.7K -73,680 -63%
FT
21
Fiduciary Trust
Massachusetts
$31K – – –
Morgan Stanley
22
Morgan Stanley
New York
$30K -$3.16K -3,549 -8%
Assenagon Asset Management
23
Assenagon Asset Management
Luxembourg
$28K -$216K -241,795 -87%
KAS
24
Kestra Advisory Services
Texas
$26K +$535 +600 +2%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$23K – – –
1
2 3

AGTC Hedge Fund Activity: Q2 2022 in Review

47 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2022, worth a combined $8.49M — down 47% from $16.2M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of AGTC and 7 opened new positions — a net loss of 5 holders — while 19 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $167K. The largest seller was Cantor Fitzgerald, cutting an estimated $2.09M.

  • 47 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2022, down from 53 in Q1 2022.
  • Funds reported $8.49M of Applied Genetic Technologies Corporation stock for Q2 2022, down 47% quarter-over-quarter.
  • 7 funds opened new Applied Genetic Technologies Corporation positions in Q2 2022 and 12 closed out, a net change of -5 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q2 2022 was Renaissance Technologies, an estimated $167K added.
  • The largest Applied Genetic Technologies Corporation seller in Q2 2022 was Cantor Fitzgerald, an estimated $2.09M sold.

Based on aggregated 13F filings for Q2 2022.